Anti-GD2 monoclonal antibody for high-risk neuroblastoma advances toward BLA submission following successful tech transfer from California to Bengaluru
Q4FY26 revenue climbs 19% to Rs. 2,290 crore as CDMO sterile injectables, radiopharma and generics businesses drive growth momentum
The biosimilars business generated Rs. 10,431 crore in FY26 revenue, up 16% year-on-year
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
Steady growth led by biologics and CRDMO business, EBITDA margin at 25% with continued investments in ADCs, peptides, and digital capabilities
CRDMO plans to add 800–1,000 women across scientific and leadership roles over three years
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
These upgrades will enable advanced development and flexible manufacturing, supporting complex therapeutics and meeting global demand for advanced pharmaceutical solutions
The Taipei facility boasts 10 GMP API production lines, with a total reactor volume exceeding 350,000 liters
One of India’s top integrated contract research, development, and manufacturing organizations (CRDMOs) is on a hiring spree
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
